ACADIA PHARMACEUTICALS INC 4
4 · ACADIA PHARMACEUTICALS INC · Filed Aug 13, 2015
Insider Transaction Report
Form 4
KAPLAN LESTER J PH D
Director
Transactions
- Exercise/Conversion
Stock option (right to buy)
2015-08-11−8,500→ 0 totalExercise: $11.00Exp: 2015-09-08→ Common Stock (8,500 underlying) - Exercise/Conversion
Common Stock
2015-08-11$11.00/sh+8,500$93,500→ 17,000 total
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option vested and became exercisable at the end of each 3-month period following the date of grant of September 9, 2005.